Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinli Lin

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
International Journal of Biological Macromolecules|December 31, 2025
Development of a chemically modified recombinant α1-antitrypsin mutant expressed in E. coli for therapeutic applicationsDongying Yang, Bo Wang, Xiaoran Wang, et al.
Diabetes Research and Clinical Practice|February 26, 2025
Global, regional and national burden and trends of disease attributable to high body mass index in adolescents and young adults from 1990 to 2021Runhong Li, Jiaqi Zhang, Menghan Zhang, et al.
BBA Advances|December 24, 2025
CEMIP promotes gefitinib resistance in lung cancer with EGFR-mutation possibly through forming a stable complex CEMIP/c-MYCLi Li, Jiaxiu Xie, Jinxing Liang, et al.
Cancer Epidemiology|June 19, 2021
The association between fatty acid intake and breast cancer based on the NHANES and Mendelian randomization studyFeng Guo, Min Wang, Xuecan Guo, et al.
FEBS Open Bio|October 20, 2018
Oxidation-resistant and thermostable forms of alpha-1 antitrypsin from <i>Escherichia coli</i> inclusion bodiesWei Zhu, Lanfen Li, Mingjing Deng, et al.
Cancer Research|April 19, 2006
Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor systemShuping Yin, Jaron Lockett, Yonghong Meng, et al.
Thrombosis Journal|February 1, 2013
Purification and characterization of mutant miniPlasmin for thrombolytic therapyXiaotao Lin, Yan Wang, Yanwen Zhang, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
International Journal of Biological Macromolecules|December 31, 2025
Development of a chemically modified recombinant α1-antitrypsin mutant expressed in E. coli for therapeutic applicationsDongying Yang, Bo Wang, Xiaoran Wang, et al.
Diabetes Research and Clinical Practice|February 26, 2025
Global, regional and national burden and trends of disease attributable to high body mass index in adolescents and young adults from 1990 to 2021Runhong Li, Jiaqi Zhang, Menghan Zhang, et al.
BBA Advances|December 24, 2025
CEMIP promotes gefitinib resistance in lung cancer with EGFR-mutation possibly through forming a stable complex CEMIP/c-MYCLi Li, Jiaxiu Xie, Jinxing Liang, et al.
Cancer Epidemiology|June 19, 2021
The association between fatty acid intake and breast cancer based on the NHANES and Mendelian randomization studyFeng Guo, Min Wang, Xuecan Guo, et al.
FEBS Open Bio|October 20, 2018
Oxidation-resistant and thermostable forms of alpha-1 antitrypsin from <i>Escherichia coli</i> inclusion bodiesWei Zhu, Lanfen Li, Mingjing Deng, et al.
Cancer Research|April 19, 2006
Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor systemShuping Yin, Jaron Lockett, Yonghong Meng, et al.
Thrombosis Journal|February 1, 2013
Purification and characterization of mutant miniPlasmin for thrombolytic therapyXiaotao Lin, Yan Wang, Yanwen Zhang, et al.
Pageof 3